Growth investment focus EHP targets growth capital in healthcare IT, care delivery, and life science services and technology, presenting a cross-sector opportunity for portfolio expansion, add-on acquisitions, and strategic partnerships with healthcare technology and services vendors.

Founder friendly Recognized as founder-friendly by Inc. Magazine for multiple years, signaling ease of deal structuring and alignment with founders, which can facilitate outreach to early-stage and founder-led healthcare startups seeking growth capital.

Recent portfolio signals Recent investment in Leading Reach and ongoing portfolio expansion indicate active deal flow and a willingness to deploy capital in network-enabled healthcare platforms, suggesting doors for interoperability, data integration, and provider-network solutions.

Senior talent momentum Multiple promotions including Principals and Vice Presidents reflect a deepening management presence, offering opportunities for co-investor diligence collaboration and leveraging EHP’s deal sourcing and portfolio value-add capabilities.

Exit and liquidity activity Historical exits such as the PAI Pharma sale to Olympus Partners demonstrate a readiness for strategic exits and liquidity events, indicating opportunities to position growth-stage healthcare tech and services companies for scalable outcomes and buy-side interest.